Linden Advisors’s Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock VHAQ.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-370,672
Closed -$19.5K 335
2023
Q4
$19.5K Hold
370,672
﹤0.01% 256
2023
Q3
$21.5K Hold
370,672
﹤0.01% 297
2023
Q2
$21.5K Hold
370,672
﹤0.01% 316
2023
Q1
$21.9K Hold
370,672
﹤0.01% 382
2022
Q4
$41.7K Hold
370,672
﹤0.01% 416
2022
Q3
$47K Hold
370,672
﹤0.01% 524
2022
Q2
$35K Hold
370,672
﹤0.01% 601
2022
Q1
$50K Hold
370,672
﹤0.01% 660
2021
Q4
$71K Hold
370,672
﹤0.01% 715
2021
Q3
$73K Hold
370,672
﹤0.01% 628
2021
Q2
$101K Buy
+370,672
New +$76.4K ﹤0.01% 765

Other funds holding VHAQ.RT

Linden Advisors's VHAQ.RT Position: Q1 2024 in Review

Linden Advisors sold out of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) in Q1 2024, closing a stake of 370,672 shares — an estimated $19.5K sold.

Linden Advisors first reported a position in VHAQ.RT in Q2 2021 and held it in 11 quarters. The position peaked at $101K in Q2 2021. 5 funds tracked by Wall St. Rank hold VHAQ.RT as of Q1 2024.

  • Linden Advisors reported no remaining Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position as of Q1 2024 after selling out during the quarter.
  • Linden Advisors sold 370,672 Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock shares in Q1 2024, an estimated $19.5K.
  • Linden Advisors first reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in Q2 2021 and held it in 11 quarters.
  • Linden Advisors's Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position peaked at $101K in Q2 2021.
  • 5 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock as of Q1 2024.

Based on Linden Advisors's 13F filing for Q1 2024, filed 15 May 2024.